# Q11 Development and Manufacture of Drug Substances - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411

> FDA guidance document: Q11 Development and Manufacture of Drug Substances. Issue date: November 20, 2012. Get complete insights and analysis.

---

## Details

- Title: Q11 Development and Manufacture of Drug Substances
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2012-11-20
- Last Changed: 2020-05-15

## Related Documents

- [S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s6-r1-addendum-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/c9774033-823e-4e54-8323-928303b9f87d)
- [S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use](https://www.globalkeysolutions.net/guidances/guidance-document/s2r1-genotoxicity-testing-and-data-interpretation-for-pharmaceuticals-intended-for-human-use/bdcb4e58-2f39-40e7-90c5-9f222d9203c1)
- [S6(R1) Addendum: Preclinical Safety Evaluation of Biotechnology:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/s6r1-addendum-preclinical-safety-evaluation-of-biotechnology-guidance-for-industry/23ee2aae-70be-4e30-bfcb-a4cf7a016b71)